Abrdn Healthcare Investors
NYSE:HQHAsset Management
+$0.15 today
- Market cap
- $1.27B
- Beta
- 0.76
- P/E (TTM)
- 4.2
- EPS (TTM)
- $4.72
- Dividend yield
- 11.57%
Volume 0.23M
Average 0.14M
HQH Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Abrdn Healthcare InvestorsNYSE: HQH
Common Stock · Q4 FY2025 · quarter ended Sep 2025
Common stock of $555.1K in Q4 FY2025
Q4 FY2025 common stock was $555.1K. Over 3 fiscal years it compounded at +5.4% a year.
Context
- Common stock amounted to 0.1% of total assets at the end of Q4 FY2025.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 555.1K USD
- Year-over-year change
- +6.5%
- 4-year CAGR
- +5.1%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 555.1K | +6.5% |
| FY2024 | 2024-12-31 | 521.3K | +5.4% |
| FY2023 | 2023-12-31 | 494.42K | +4.4% |
| FY2022 | 2022-12-31 | 473.44K | +4.2% |
| FY2021 | 2021-12-31 | 454.25K | — |
Common Stock vs competitors
How HQH compares with its peers on the latest reported figures
- HQH's Sep 2025 common stock of $555.1K is the 3rd highest of the 10 companies compared; the peer median is $88K.
- Common stock amounts to 0.1% of total assets for HQH, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.08M | +0.0% | +2.3% | 0.0% | |
| Mar 2026 | $703K | -3.6% | +12.0% | 0.0% | |
| Sep 2025 | $555.1K | — | +5.4% | 0.1% | |
| Mar 2026 | $124K | +0.8% | +0.8% | 0.0% | |
| Mar 2026 | $99K | +3.1% | +30.1% | 0.0% | |
| Mar 2026 | $88K | +37.5% | +32.8% | 0.0% | |
| Mar 2026 | $85K | -9.6% | +12.3% | 0.0% | |
KBDCKayne Anderson BDC, Inc. | Mar 2026 | $66K | -7.0% | +23.6% | 0.0% |
| Mar 2026 | $65K | +0.0% | +0.0% | 0.0% | |
| Mar 2026 | $53K | +17.8% | +20.7% | 0.0% | |
| Peer median (excluding HQH) | $88K | +0.0% | +12.3% | 0.0% | |
Competitors are the stored peer set for HQH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Abrdn Healthcare Investors
NYSE:HQH
Intrinsic Alpha fair value
Locked
Current Price
$22.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.